Ride to Conquer Cancer
TalentSphere was proud to support one of our own Stephen Borer in the 2017 Ride to Conquer Cancer, Vancouver.
$8.3 million for BC Cancer Foundation.
$67k from Team Cyclepath Kelowna
For more information on the BC Ride to Conquer Cancer, please see http://va17.conquercancer.ca
Funds from the Ride have:
- Supported more than 47 projects, investigating more than 50 different cancer types
- Enabled more than 300 patients to be submitted to POG
First-of-its-kind, the Personalized Onco-Genomics Program allows world-leading scientists and doctors to map the genomic structure enrolled patient’s cancer to help determine potential drug targets and treatment based on a biological rationale. Funds raised through The Ride are enabling the BC Cancer Agency to continue enrolling patients into this ground-breaking clinical study.
- Supported the construction of the Conconi Immunotherapy Lab
Funds continue to support incredible progress for the BC Cancer Agency’s Immunotherapy research program, as well as the newly constructed Conconi Lab within the Deeley research Centre at the Vancouver Island Cancer Centre, in Victoria, establishing the provincial hub of immunotherapy treatment and development. Support will help make T cell therapy a reality for cancer patients in B.C., bringing a critical new treatment solution to the clinic.
- Supported the development of Canadian-first “OncoPanel” with more than 2,000 BC cancer patients eligible annually
A new multi-gene analysis panel is now available to oncologists across B.C. as a provincial diagnostic tool, meaning a more personalized approach to treatment for thousands of eligible cancer patients. This is the first gene panel to be available province-wide and as part of standard cancer care in Canada for acquired cancers.
- Enhanced brain cancer care
Brain cancer care in B.C. has been transformed, enabling patients to be seen by neuro-oncology specialists quickly and effectively, in one visit and at one site.
- Supported a new drug for advanced prostate cancer to enter clinical trials
Funds will further support a new prostate cancer drug developed at BC Cancer Agency called EPI-506 that is currently in clinical trial. This new treatment option offers hope for the thousands impacted by prostate cancer in B.C. and around the world.
- Purchased a second state-of-the-art PET/CT scanner & reduced wait times
— Funds raised through The Ride supported the purchase of the BC Cancer Agency’s second PET/CT scanner and allowed for an upgrade to an existing scanner. As a result, wait times have been reduced and the number of patients able to receive these life-saving scans have doubled.